Background: Left ventricular (LV) hypertrophy caused by aortic valve stenosis (AS) leads to cardiovascular morbidity and mortality. We sought to determine whether aortic valve replacement (AVR) decreases LV mass and improves LV function. Materials and Methods: Retrospective review for 358 consecutive patients, who underwent aortic valve replacement for degenerative AS between January 1995 and December 2008, was performed. There were 230 men and 128 women, and their age at operation was 63.2±10 years (30∼85 years). Results: There was no in-hospital mortality, and mean follow-up duration after discharge was 48.9 months (2∼167 months). Immediate postoperative echocardiography revealed that LV mass index and mean gradient across the aortic valve decreased significantly (p＜0.001), and LV mass continued to decrease during the follow-up period (p＜0.001). LV ejection fraction (EF) temporarily decreased postoperatively (p＜0.001), but LV function recovered immediately and continued to improve with a significant difference between preoperative and postoperative EF (p＜0.001). There were 15 late deaths during the follow-up period, and overall survival at 5 and 10 years were 94% and 90%, respectively. On multivariable analysis, age at operation (p=0.008), concomitant coronary bypass surgery (p＜0.003), lower preoperative LVEF (＜40%) (p=0.0018), and higher EUROScore (＞7) (p=0.045) were risk factors for late death. Conclusion: After AVR for degenerative AS, reduction of left ventricular mass and improvement of left ventricular function continue late after operation.
INTRODUCTION
Degenerative aortic valve stenosis (AS) is one of the most frequently encountered acquired heart disease [1] . The prognosis of symptomatic AS with severe left ventricular hypertrophy is very poor, and expected survival after the development of symptoms, such as dyspnea, syncope and angina, is less than 2 years [2] . Severe AS in elderly is also associated with a high mortality, and life expectancy of octogenarians with severe AS is known to be less than 1 year [1] . Aortic valve replacement (AVR) employing cardiopulmonary bypass has been the standard treatment for patients with severe AS.
Left ventricular (LV) hypertrophy, which is caused by pressure overload of the LV, is believed to increase the risk of heart failure, cerebrovascular accident and sudden death. SD=Standard deviation; NYHA Fc=New York heart association functional class; ECMO=Extra-corporeal membrane oxygenation; CVA=Cerebrovascular accident (stroke); COPD=Chronic obstructive pulmonary disease. trophy, and LVMI is known to decrease after the reduction of LV afterload by AVR [3] . However, decrease in LVMI after AVR is slow or stagnant in some patients, and late outcome of AVR in this subset is reportedly worse than that of others with rapid regression of LV hypertrophy [4] , which may well be attributed to left ventricular diastolic dysfunction and stenotic nature of ventricular hypertrophy with mal-coordination between the LV and prosthetic aortic valve [5] . In this study, we sought to determine the impact of AVR on LV mass and function, and we conducted risk factor analysis for late mortality after AVR.
MATERIALS AND METHODS
Among the 407 patients who underwent AVR for AS from January 1995 to December 2008, 358 patients were selected for the analysis after excluding 12 with rheumatic valvular heart disease and 37 patients who underwent coronary artery bypass surgery with concomitant AVR for moderate AS which did not correspond to our indications for AVR (Fig.   1 ). There were 230 men and 128 women, and their age at operation was 63.2±10 years (30∼85 years). Among them, 102 patients (102/358, 28.5%) were older than 70 years, and 12 (12/358, 3.5%) were older than 80 years. Preoperative variables, such as New York heart association (NYHA) functional class, smoking history, European system for cardiac operative risk evaluation (Euroscore) [6] , and the presence of 
2) Surgical technique
Under general anesthesia and installation of trans-esophageal echocardiography probe, surgical procedures were performed through median sternotomy and moderately hypothermic cardiopulmonary bypass. Supra-annular prosthetic valve implantation technique has been employed from 2003.
In principle, tissue valves were used for the elderly (＞65 years) and mechanical valves were used in the younger patients. 
3) Statistical analysis

RESULTS
There was no in-hospital mortality, and mean follow-up duration after discharge was 48.9 months (2∼167 months).
Follow-up was complete in 97% of the patients, and most of them (83%) have been followed up in our institution. Survival of the patients who were missing from follow-up (2.7%) was ascertained using the database from the 'Statistics Fig. 2 ). There were 15 late deaths during the follow-up period: six died of malignant neoplasm, 3 died of congestive heart failure and 2 died of cerebrovascular accident (Table 4) . Overall survival at 5 and 10 years were 94% and 90%, respectively. Among the 3 patients who died of congestive heart failure, 2 had preoperative LVEF of lower than 40%. On univariable analysis, age at opSumin Shin, et al [11] . However, ventricular hypertrophy, which is attributed to chronic pressure overload to the LV, is believed to be more important prognostic factor than the pressure gradient across the prosthetic AV [12] . In a study pertaining to systemic hypertension, ventricular hypertrophy was associated with decreased survival by myocardial ischemia, systolic and diastolic dysfunction, and ventricular arrhythmia which may lead to sudden death [13, 14] . To the contrary, AVR for aortic stenosis is reportedly associated with left ventricular mass reduction, stabilization of the ventricular electrical instability, and improvements in myocardial ischemia, and, hence, improved functional capacity and long-term outcome [11] . In this study, reduction of the ventricular mass was observed immediate postoperatively, and LV mass continued to regress as time passed. Delay in the improvements in LV ejection fraction is believed to be associated with myocardial fibrosis [15] .
Mortality after AVR in octogenarians has reportedly decreased from 14% [16] to 2.4∼5% [17, 18] , which is consistent with the results from this study. In our series, there was no early mortality regardless of the age at operation or the presence of associated cardiac diseases, and one of the major causes of late deaths was malignancy. Three patients died of congestive heart failure, two of whom showed decreased LV ejection fraction (＜40%) preoperatively. risk factors for late death turned out to be age at operation, concomitant coronary artery bypass surgery, and preoperative LV dysfunction (LV ejection fraction ＜40%). In other reports, postoperative changes in NYHA functional class [19] and pressure gradient across the AV [20] were identified as prognostic factors for late survival.
One of the peri-operative factors which excellent early and late outcome of this series could be attributed to is our vigorous attempts to ascertain any calcification in the thoracic aorta. To this end, we routinely conducted preoperative cardiac computed tomography, intra-operative transesophageal echocardiographic monitoring, and, more recently, intra-operative epiaortic echocardiography prior to the surgical intervention of the aorta. Relatively younger age at operation compared to other series, AVR by cardiac surgeons who exclusively perform valve surgery, and higher valve size-body weight ratio with lower postoperative residual trans-aortic pressure gradient could well be contributing factors for better outcome too. To implant bigger-sized prosthetic valves, we have employed supra-annular valve implantation technique and aortic annulus enlargement procedures. Thanks to these aggressive maneuvers, only 24 patients (6.7%) showed residual mean trans-aortic gradient greater than 20 mmHg on postoperative one-year echocardiography ( Table 2 ). Retrospective study design, and, as a result, significant missing data in the earlier cohort, are limitations of this study. 
